Call us today for help! (214) 295-5011
The first new mesothelioma therapy approved by the FDA is based on a trial. In this single-arm STELLAR trial, the median overall survival rate was 18.2 months with patients with unresectable, locally advanced or metastatic malignant pleural mesothelioma who received TTF plus chemotherapy. This combination of treatments comprises the NovoTTF-100L System along with pemetrexed and …
It is a proven fact that asbestos exposure can develop into deadly mesothelioma. But how does this happen to healthy cells? Microscopic asbestos fibers are inhaled into the lungs, yet the deadly mesothelioma disease can appear in physically remote mesothelial cells¹. Latest experiments Arti Shukla, Ph.D., associate professor of pathology and laboratory medicine at the …
In a study by researchers led by Dr. Antonio Giordano at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University and his colleagues at the University of Siena, Italy, a potential new treatment for mesothelioma appears promising. This treatment involves repurposing a drug already approved for the treatment of pinworm parasite infections. …
When a patient is diagnosed with mesothelioma, a disease stage is also assigned. The stage determines the treatment plan for the patient. These standards for stage evaluation have been updated through a project led by Dr. Valerie Rusch, renowned mesothelioma specialist from Memorial Sloan Kettering Cancer Center in New York. This re-categorization will lead to …
Too often, cancer patients and their families must choose between traditional hospice limited to palliative care and active treatment of their disease. Fortunately, the Veterans Health Administration (VA) has taken a lead in offering both hospice/palliative care and cancer therapy concurrently in the United States (US). This is a major step in what has been …
